Cetilistat
Cetilistat is a novel inhibitor of pancreatic lipase being developed by Alizyme for the treatment of obesity and associated co-morbidities, including type 2 diabetes.
| Catalog Number | T3283 |
| Alternative Name(s) | ATL-962 |
| Research Area | Metabolism |
| Molecular Formula | C25H39NO3 |
| CAS# | 282526-98-1 |
| Purity | 99.88% |
| SMILES | CCCCCCCCCCCCCCCCOc1nc2c(cc(cc2)C)c(=O)o1 |
| Size | 100 mg |
| Supplier Page | https://www.targetmol.com/compound/Cetilistat |
| Additional Information | https://www.targetmol.com/datasheet/T3283 |